| Literature DB >> 33727774 |
Guo-Liang Zheng1, Bao Zhang1, Yue Wang1, Yong Liu1, Hai-Tao Zhu1, Yan Zhao1, Zhi-Chao Zheng2.
Abstract
BACKGROUND: Various surgical procedures have been described for gastrointestinal stromal tumors (GISTs) at the esophagogastric junction (EGJ) close to the Z-line. However, surgery for EGJ-GIST involving Z-line has been rarely reported. AIM: To introduce a novel technique called conformal resection (CR) for open resection of EGJ-GIST involving Z-line.Entities:
Keywords: 36-Item short-form health survey; Anti-reflux; Disease-free survival; Esophagogastric junction stromal tumor; Surgery
Mesh:
Year: 2021 PMID: 33727774 PMCID: PMC7941860 DOI: 10.3748/wjg.v27.i9.854
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742
Figure 1Schematic diagram of esophagogastric junction-gastrointestinal stromal tumor. Z-line: Squamocolumnar junction; Type A: Defined as esophagogastric junction-gastrointestinal stromal tumor involving Z-line; Type B: Defined as esophagogastric junction-gastrointestinal stromal tumor near Z-line.
Figure 2Conformal resection of type A esophagogastric junction-gastrointestinal stromal tumor located in the anterior wall of esophagogastric junction. A: The abdominal computed tomography showing the lesion located in the anterior wall of the esophagogastric junction; B: Exploratory laparotomy; C: Removal of the tumor with preservation of esophagogastric junction and esophageal wall as much as possible; D: Suturing of the esophageal wall to the gastric wall to prevent stenosis; E: The final appearance after suturing.
Figure 3Conformal resection of type A esophagogastric junction-gastrointestinal stromal tumor located in the posterior wall of esophagogastric junction. A: The abdominal computed tomography showing the lesion located in posterior wall of the esophagogastric junction; B: Anterior gastrotomy to visualize the lesion; C: Removal of the tumor; D: Suturing of the posterior wall of the esophagus to the gastric wall.
Figure 4Gastroduodenal endoscopy 2 mo after the operation. A: Gastric view; B: Esophageal view.
Comparison of clinical and pathologic variables of study patients
|
|
|
|
|
| Age, median (range), in yr | 58 (32-73) | 61 (28-75) | 0.532 |
| Sex | 0.168 | ||
| Male | 8 | 16 | |
| Female | 10 | 9 | |
| Size in cm | 0.549 | ||
| ≤ 2 | 1 | 0 | |
| 2.1-5.0 | 6 | 6 | |
| 5.1-10 | 7 | 13 | |
| > 10 | 4 | 6 | |
| Histologic type | 0.71 | ||
| Spindle | 13 | 18 | |
| Epitheloid | 1 | 3 | |
| Mixed | 4 | 4 | |
| Mitotic index, per 50 HPF | 0.766 | ||
| ≤ 5 | 13 | 17 | |
| > 5 | 5 | 8 | |
| Ki-67 | 0.163 | ||
| ≤ 5% | 15 | 16 | |
| > 5% | 3 | 9 | |
| CD117 | 0.929 | ||
| Positive | 16 | 22 | |
| Negative | 2 | 3 | |
| CD34 | 0.159 | ||
| Positive | 15 | 24 | |
| Negative | 3 | 1 | |
| DOG-1 | 0.083 | ||
| Positive | 13 | 23 | |
| Negative | 5 | 2 | |
| NIH risk category | 0.476 | ||
| Very low risk | 1 | 0 | |
| Low risk | 5 | 4 | |
| Intermediate risk | 7 | 12 | |
| High risk | 5 | 9 | |
| Length of the upper edge of the GIST crossing the Z-line, mean ± SD (cm) | 0.639 (0.29) | 1.024 (0.395) | 0.193 |
| Circumference of the EGJ involvement | 0.716 | ||
| T ≤ 1/4 | 10 | 13 | |
| 1/4 < T ≤ 2/4 | 7 | 8 | |
| 2/4 < T ≤ 3/4 | 1 | 3 | |
| T > 3/4 | 0 | 1 | |
| Heartburn, postoperative | |||
| Yes | 3 | 16 | 0.004 |
| No | 15 | 9 | |
| Oral antacids, postoperative | |||
| Yes | 4 | 18 | 0.002 |
| No | 14 | 7 |
CR: Conformal resection; EGJ: Esophagogastric junction; GIST: Gastrointestinal stromal tumor; HPF: High-power field; PG: Proximal gastrectomy; T: Tumor.
Comparison of intra-operative and postoperative variables between two surgical procedures for type A esophagogastric junction-gastrointestinal stromal tumors
|
|
|
|
|
| |
|
|
| ||||
| Operating time in min | 108.61 ± 30.13 | 137.80 ± 51.04 | 0.029 | -56.41 | -0.97 |
| Intraoperative blood loss in mL | 59.44 ± 23.08 | 90.60 ± 35.62 | 0.069 | -53.53 | -11.78 |
| First passage of flatus time in h | 29.11 ± 15.35 | 74.24 ± 40.39 | 0.013 | -65.389 | -24.87 |
| Days to oral intake | 3.56 ± 1.65 | 8.68 ± 3.88 | 0.006 | -7.09 | -3.16 |
| Postoperative hospital stay in d | 6.00 ± 2.40 | 10.96 ± 4.15 | 0.049 | -7.17 | -2.75 |
| Negative margin, % | 100 | 100 | |||
CI: Confidence interval; CR: Conformal resection; PG: Proximal gastrectomy.
Postoperative esophageal 24-h pH parameters of patients who underwent surgery for type A esophagogastric junction-gastrointestinal stromal tumors
|
|
|
|
|
| |
|
|
| ||||
| CR group, | 4.97 ± 1.44 | 31.83 ± 22.65 | 17.83 ± 11.25 | 35.62 ± 15.71 | 1.44 ± 1.68 |
| PG group, | 3.41 ± 1.15 | 184.48 ± 118.74 | 32.68 ± 15.89 | 58.81 ± 19.13 | 6.04 ± 1.92 |
|
| < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
CR: Conformal resection; PG: Proximal gastrectomy.
Postoperative health-related quality of life of study patients
|
|
|
|
|
|
|
|
|
|
| CR group, | 53.72 ± 2.13 | 54.61 ± 1.61 | 60.94 ± 1.86 | 61.56 ± 1.75 | 61.72 ± 3.49 | 55.11 ± 2.24 | 50.61 ± 2.93 | 55.00 ± 2.27 |
| PG group, | 48.00 ± 3.64 | 48.36 ± 2.89 | 49.80 ± 4.12 | 50.72 ± 5.15 | 52.20 ± 4.06 | 44.60 ± 2.63 | 37.16 ± 4.08 | 46.12 ± 3.95 |
|
| < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
BP: Bodily pain; GH: General health; MH: Mental health; PF: Physical function; RE: Role-emotional; SF: Social functioning; RP: Role physical; VT: Vitality.
Figure 5The receiver operating characteristic curve analyses showed that the best cut-off value of distance of involving Z-line was 7.0 mm.
Figure 6The disease-free survival between conformal resection group and proximal gastrectomy group ( CR: Conformal resection; PG: Proximal gastrectomy.